Prof. Dr. Oliver Schwarz
Schwarz

Forschungsschwerpunkte:

  • Marketingforschung
  • Statistische Methoden der BWL
  • Gesundheitsökonomie

Veröffentlichungen (Auswahl):

  • M. Schlander, M.A. Khan, A. Iezzi, A. Maxwell, O. Schwarz, J. Richardson: The Measurement of health-related Quality of Life: German Findings from the Multi-Instrument Comparison (MIC) Study. Value in Health 16 [7] (2013) A330.
  • M. Schlander, O. Schwarz, G.-E. Trott, T. Banaschewski: Attention-Deficit Hyperactivity Disorder (ADHD), 2003-2009: A Longitudinal Analysis of Prevalence, Health Care and Direct Cost Based upon Administrative Data from Nordbaden / Germany. Symposium. European Child + Adolescent Psychiatry 22 [Suppl. 2] (2013) S102 (Abstract No. S2-06-05).
  • O. Schwarz, M. Schlander: Mental Health Care Research in Germany: Sociodemographic Characteristics of the Nordbaden Database. European Child + Adolescent Psychiatry 22 [Suppl. 2] (2013) S100 (Abstract No. S2-06-01).
  • G.-E. Trott, O. Schwarz, T. Banaschewski, W. Scheller, M. Viapiano, N. Bonauer, M. Schlander: The Rising Administrative Prevalence of Attention-Deficit Hyperactivity Disorder (ADHD) in Nordbaden /Germany and Specialist Involvement in Health Care Provision. European Child + Adolescent Psychiatry 22 [Suppl. 2] (2013) S101-102 (Abstract No. S2-06-04).
  • T. Banaschewski, O. Schwarz, G.-E. Trott, W. Scheller, M. Viapiano, N. Bonauer, M. Schlander: The Evolving Treatment Patterns for Attention-Deficit Hyperactivity Disorder (ADHD) in Nordbaden /Germany: A Retrospective Study Based upon Administrative Data, Years 2003-2009. European Child + Adolescent Psychiatry 22 [Suppl. 2] (2013) S101 (Abstract No. S2-06-03).
  • M. Schlander, O. Schwarz, G.-E. Trott, T. Banaschewski, W. Scheller, M. Viapiano, N. Bonauer: The Medical Cost Attributable to Attention-Deficit Hyperactivity Disorder (ADHD) in Nordbaden / Germany: A Study From a Health Care Payer’s Perspective Based on Claims Data. European Child + Adolescent Psychiatry 22 [Suppl. 2] (2013) S100-101 (Abstract No. S2-06-02).
  • M. Schlander, G.E. Trott, T. Banaschewski, O. Schwarz: New Estimates of the Direct Medical Cost of Attention-Deficit/Hyperactivity Disorder (ADHD) in Germany. Value in Health Vol. 16 Issue 7 (2013), Page A546
  • M. Schlander, T. Banaschewski, G.E. Trott, O. Schwarz: Medication Treatment and Health Care Utilization for Attention-Deficit/Hyperactivity Disorder (ADHD) in Germany. Value in Health Vol. 16, Issue 7 (2013), Page A340
  • M. Schlander, O. Schwarz: Health Care Utilization Research in Germany: Characterization of the Nordbaden Database. 15th Annual European Congress of the International Society for Pharmacoeconomics & Outcomes Research (ISPOR), Berlin / Germany, November 03-07, 2012. Value in Health 15 [7] (2012) A303
  • M. Schlander,O. Schwarz, G.-E. Trott, T. Banaschewski, W. Scheller, M. Viapiano, N. Bonauer: Most Frequently Diagnosed Mental Health Problems in a German Population. 15th Annual European Congress of the International Society for Pharmacoeconomics & Outcomes Research (ISPOR), Berlin / Germany, November 03-07, 2012. Value in Health 15 [7] (2012) A344.
  • M. Schlander, O. Schwarz, T. Banaschewski, G.-E. Trott, M. Viapiano, N. Bonauer, W. Scheller: Involvement of CNC Specialists in Health Care Provision for Patients with Attention-Deficit / Hyperactivity Disorder (ADHD): New Data from Nordbaden, Germany, 2003 – 2009. 15th Annual European Congress of the International Society for Pharmacoeconomics & Outcomes Research (ISPOR), Berlin / Germany, November 03-07, 2012. Value in Health 15 [7] (2012) A535.
  • M. Schlander, O. Schwarz, A. Rothenberger, V. Roessner: Tic disorders: prevalence and co-occurrence with attention-deficit/hyperactivity disorder in a German community sample. European Psychiatry, 2011, Volume 26, Issue 6, S. 370 - 374.
  • M. Schlander, O. Schwarz, G,-E. Trott, T. Banaschewski, M. Viapiano, N. Bonauer: Increasing Use of Medication for Treatment of Attention Deficit hyperactivity Disorder (ADHD) in Germany between 2003 and 2009. 14th Annual European Congress of the International Society for Pharmacoeconomics & Outcomes Research (ISPOR), Madrid / Spain, November 05-08, 2011. Value in Health 14 [7] (2011) A300.
  • M. Schlander, A. Philipsen, O. Schwarz, and the COMPAS Study Group: The Cost Effectiveness of Clinically Proven Treatment Strategies for ADHD in Adult Patients. 14th Annual European Congress of the International Society for Pharmacoeconomics & Outcomes Research (ISPOR), Madrid / Spain, November 05-08, 2011. Value in Health 14 [7] (2011) A403.
  • M. Schlander, G.-E. Trott, O. Schwarz: Gesundheitsökonomie der Aufmerksamkeitsdefizit-Hyperaktivitätsstörung (ADHS) in Deutschland – Teil 1: Versorgungsepidemiologie und Krankheitskosten. Der Nervenarzt, 2010, Volume 81 (3), S. 289 - 300.
  • M. Schlander, G.-E. Trott, O. Schwarz: Gesundheitsökonomie der Aufmerksamkeitsdefizit-Hyperaktivitätsstörung (ADHS) in Deutschland – Teil 2: Therapeutische Optionen und ihre Kosteneffektivität. Der Nervenarzt, 2010, Volume 81 (3), S. 301 - 314.
  • O. Schwarz: Absicherung des Net Promoter Score - die Ermittlung von Konfidenzintervallen mit dem Bootstrap Verfahren. Der Markt – Journal für Marketing, 48 (3), 2009, S. 105 - 115.
  • M. Schlander, O. Schwarz, G.-E. Trott, M. Viapiano, N. Bonauer: Who Cares for Patients with Attention-Deficit/Hyperactivity Disorder? Insights from Nordbaden (Germany). European Child & Adolescent Psychiatry, 16 (7), 2007, S. 430 - 438.
  • M. Schlander, O. Schwarz: Finanzierbarkeit steigender Gesundheitsausgaben in Deutschland: eine makroökonomische Betrachtung. Gesundheitsökonomie & Qualitätsmanagement 10, 2005, S. 178 - 187.
  • O. Schwarz: Kundenanalysen zur Erhöhung von Responseraten im Database Marketing; in: Studium Duale - Jahrbuch der Berufsakademie Mannheim 2005.